Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.906687
Abstract: Dexamethasone may reduce mortality in COVID-19 patients. Whether dexamethasone or endogenous glucocorticoids, such as cortisol, biochemically interact with SARS-CoV-2 spike 1 protein (S1), or its cellular receptor ACE2, is unknown. Using molecular dynamics (MD) simulations…
read more here.
Keywords:
cortisol dexamethasone;
interaction;
interaction ace2;
sars cov ... See more keywords